Compounds > t0156
Page last updated: 2024-08-16

t0156 and cyclic gmp

t0156 has been researched along with cyclic gmp in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujishige, K; Inoue, H; Kikkawa, K; Kotera, J; Mochida, H; Noto, T; Omori, K; Sasaki, T; Takagi, M; Yano, K; Yuasa, K1
Alvarez, E; Cairrão, E; Morgado, M; Santos-Silva, AJ; Verde, I1
Huang, Y; Lau, CW; Lee, VW; Leung, FP; Liu, CQ; Lu, L; Yao, X1
Chung, E; Ohgami, Y; Quock, LP; Quock, RM; Zhang, Y1
Bagcivan, I; Durmus, N; Parlak, A; Yildirim, S1

Other Studies

5 other study(ies) available for t0156 and cyclic gmp

ArticleYear
Enzymological and pharmacological profile of T-0156, a potent and selective phosphodiesterase type 5 inhibitor.
    European journal of pharmacology, 2002, Dec-05, Volume: 456, Issue:1-3

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Anesthesia; Animals; Binding, Competitive; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Isoenzymes; Kinetics; Male; Muscle Contraction; Naphthyridines; Penile Erection; Penis; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrimidines; Rabbits; Radioligand Assay

2002
PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.
    European journal of pharmacology, 2008, Mar-17, Volume: 582, Issue:1-3

    Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Colforsin; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; Female; Guanylate Cyclase; Histamine; Humans; In Vitro Techniques; Isoenzymes; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Naphthyridines; Nitroprusside; Phosphodiesterase 4 Inhibitors; Phosphodiesterase 5 Inhibitors; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Serotonin; Umbilical Arteries; Vasodilator Agents

2008
Prevention of nitroglycerin tolerance in vitro by T0156, a selective phosphodiesterase type 5 inhibitor.
    European journal of pharmacology, 2008, Aug-20, Volume: 590, Issue:1-3

    Topics: Animals; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Drug Tolerance; Male; Naphthyridines; Nitric Oxide; Nitroglycerin; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Pyrimidines; Rats; Rats, Sprague-Dawley; Vasodilation

2008
Involvement of a NO-cyclic GMP-PKG signaling pathway in nitrous oxide-induced antinociception in mice.
    European journal of pharmacology, 2011, Mar-11, Volume: 654, Issue:3

    Topics: Analgesics; Animals; Benzoates; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Glyburide; Imidazoles; Male; Mice; Naphthyridines; Nitric Oxide; Nitrous Oxide; Oxadiazoles; Pyrimidines; Quinoxalines; Signal Transduction; Thionucleotides

2011
Role of new agents affecting NO/cGMP pathway on ovalbumin-sensitized guinea pig trachea.
    Experimental lung research, 2012, Volume: 38, Issue:8

    Topics: Animals; Asthma; Bronchodilator Agents; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Isometric Contraction; Male; Muscle, Smooth; Naphthyridines; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Ovalbumin; Pyridines; Pyrimidines; Trachea

2012